Apoptosis and Proliferation Signaling Mediated by FADD
FADD 介导的细胞凋亡和增殖信号
基本信息
- 批准号:6760990
- 负责人:
- 金额:$ 27.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyteCD3 moleculeT lymphocyteapoptosiscell linechimeric proteinscyclin dependent kinasecytokine receptorsembryogenesisembryonic stem cellendopeptidasesgene targetinggenetically modified animalslaboratory mouseligandslymphocyte proliferationlymphopoiesismutantphosphorylationprotein structure functionsite directed mutagenesistumor necrosis factor alphayeast two hybrid system
项目摘要
DESCRIPTION: (provided by applicant) Balanced cell proliferation and death is
crucial for homeostasis in mammals. Excessive or insufficient proliferation or
cell death could lead to cancerous conditions, autoimmunity, immunodeficiency,
and neurodegenerative diseases. Several closely related receptors including
tumor necrosis factor receptor I, Fas, and death receptors (DR) 3 and 4/5 can
trigger apoptotic death upon ligand engagement. Ablation of Fas mediated
apoptosis results in lymphoproliferation disease and autoimmunity. Ligand of
DR4/5 was found to kill only tumor but not normal cells. Apoptosis signaling of
all four receptors appears to be transduced by the adaptor FADD protein and the
protease Caspase 8. Surprisingly, FADD-deficiency not only abrogates apoptosis
but also causes defective proliferation in T lymphocytes, and probably in other
cell types, which leads to early embryonic lethality in mouse. This indicates
that FADD may have additional roles in alternative signaling pathways, not
necessarily related to cell death. Although there is a reasonable understanding
of the mechanism of FADD-mediated apoptosis, it is not clear how FADD regulates
cell proliferation required for embryogenesis and lymphocytes development and
proliferation. Further dissection of multi-functions of FADD will help reveal
novel pathways, which may be targets for therapeutic intervention of many
diseases. In this proposed study, recently developed inducible gene targeting
and novel transgenetic approaches will be employed to further analyze the
physiological function of FADD in mice, in order to help map the signaling
network involving FADD. Specifically our objectives are: (1) Using the
FADD-deficient+RAG-1-deficient double mutant chimeric mouse model to analyze
the T cell proliferation defects. Tissue-specific and inducible FADD-deficient
mouse models will be developed to analyze the temporal requirement of FADD
function during embryogenesis, and lymphocyte development and proliferation.
(2) To dissect multi-functions of FADD by biochemical and transgenic
approaches, involving mutational analysis of FADD in cell lines and in mouse.
(3) To investigate the role of FLIP and Caspase 8 in FADD-mediated
proliferation by in vitro and in vivo mutational studies.
描述:(由申请人提供)平衡的细胞增殖和死亡是
对哺乳动物的体内平衡至关重要。过度或不足的增殖或
细胞死亡可能导致癌性疾病,自身免疫性,免疫缺陷,
和神经退行性疾病。几个密切相关的受体,包括
肿瘤坏死因子受体I,FA和死亡受体(DR)3和4/5可以
配体参与后触发凋亡死亡。 FAS介导的消融
凋亡导致淋巴增生疾病和自身免疫性。配体
发现DR4/5仅杀死肿瘤,但不能杀死正常细胞。凋亡信号传导
所有四个受体似乎都被衔接子FADD蛋白和
蛋白酶caspase 8。令人惊讶的是,FADD缺陷不仅消除了凋亡
但还会导致T淋巴细胞中的增殖不良,可能在其他
细胞类型,导致小鼠的早期胚胎致死性。这表明
FADD在替代信号通路中可能具有其他角色,而不是
一定与细胞死亡有关。虽然有合理的理解
关于FADD介导的凋亡的机制,尚不清楚FADD如何调节
胚胎发生和淋巴细胞发育所需的细胞增殖和
增殖。进一步解剖FADD的多功能将有助于揭示
新途径,这可能是许多许多人治疗干预的靶标
疾病。在这项拟议的研究中,最近开发的诱导基因靶向
并将采用新颖的转化方法来进一步分析
FADD在小鼠中的生理功能,以帮助映射信号
涉及FADD的网络。特别是我们的目标是:(1)使用
FADD缺陷+RAG-1缺陷双突变体嵌合小鼠模型分析
T细胞增殖缺陷。组织特异性和诱导的FADD缺陷
将开发鼠标模型来分析FADD的时间要求
胚胎发生过程中的功能,淋巴细胞发育和增殖。
(2)通过生化和转基因解剖FADD的多功能。
方法,涉及细胞系和小鼠中FADD的突变分析。
(3)研究FLIP和caspase 8在FADD介导的作用
体外和体内突变研究的增殖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JIANKE ZHANG其他文献
JIANKE ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JIANKE ZHANG', 18)}}的其他基金
Targeting RIP1-mediated pathways for immune homeostasis and tolerance
靶向 RIP1 介导的免疫稳态和耐受途径
- 批准号:
9113902 - 财政年份:2016
- 资助金额:
$ 27.95万 - 项目类别:
Targeting Daxx-mediated complex for autoimmune diseases
靶向 Daxx 介导的复合物治疗自身免疫性疾病
- 批准号:
8493108 - 财政年份:2013
- 资助金额:
$ 27.95万 - 项目类别:
Targeting Daxx-mediated complex for autoimmune diseases
靶向 Daxx 介导的复合物治疗自身免疫性疾病
- 批准号:
8728728 - 财政年份:2013
- 资助金额:
$ 27.95万 - 项目类别:
Apoptosis and Proliferation Signaling Mediated by FADD
FADD 介导的细胞凋亡和增殖信号
- 批准号:
6928562 - 财政年份:2002
- 资助金额:
$ 27.95万 - 项目类别:
相似海外基金
Engineering and Testing of Biomimetic Stimulators for Therapeutic Applications
用于治疗应用的仿生刺激器的工程和测试
- 批准号:
10705808 - 财政年份:2022
- 资助金额:
$ 27.95万 - 项目类别:
Engineering and Testing of Biomimetic Stimulators for Therapeutic Applications
用于治疗应用的仿生刺激器的工程和测试
- 批准号:
10570359 - 财政年份:2022
- 资助金额:
$ 27.95万 - 项目类别:
Pathogenesis of the cART unresponsive Kaposi’s sarcoma tumor niche
cART 无反应卡波西肉瘤肿瘤微环境的发病机制
- 批准号:
10669148 - 财政年份:2019
- 资助金额:
$ 27.95万 - 项目类别:
Synergistic combinations that target apoptosis induction in PTCL
针对 PTCL 细胞凋亡诱导的协同组合
- 批准号:
10005245 - 财政年份:2019
- 资助金额:
$ 27.95万 - 项目类别:
Synergistic combinations that target apoptosis induction in PTCL
针对 PTCL 细胞凋亡诱导的协同组合
- 批准号:
10477038 - 财政年份:2019
- 资助金额:
$ 27.95万 - 项目类别: